Achieve Life Sciences (ACHV) Financials

$7.06

$-0.22 (-3.02%)

As on 11-Sep-2026 16:00EDT

Market cap

$726 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

64

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.17	0.23	0.23	0.23	0.24	0.25
Gross Profit	-0.17	-0.23	-0.23	-0.23	-0.24	-0.25
Operating Expenses	58.17	54.65	38.84	27.25	40.80	33.09
Operating Profit (EBIT)	-58.28	-54.88	-39.07	-27.25	-40.80	-33.09
Other Income	--	--	--	--	0.24	--
Profit before Tax	-114.04	-54.65	-39.83	-29.82	-42.35	-33.15
Provision for Tax	--	--	-39.83	--	-0.48	-0.25
Profit after Tax (Net Income)	-114.04	-54.65	-39.83	-29.82	-41.88	-32.90
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-42.35	-33.15

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-14.68	21.52	20.90	-1.45	8.30	28.04
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.46	11.19	11.05	0.01	0.07	14.92
Current Liabilities	197.66	9.08	6.68	20.81	21.60	4.55
Total Liabilities	388.10	41.79	38.63	19.37	29.97	47.52

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	2.15	1.90	2.17	2.39	2.64	2.92
Current Assets	188.29	39.89	36.47	16.98	27.33	44.59
Total Assets	388.10	41.79	38.63	19.37	29.97	47.52
Total Debt*	14.95	14.96	9.96	16.73	16.20	14.99
Net Current Assets	-9.36	30.81	29.79	-3.83	5.73	40.04

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-49.47	-29.77	-24.48	-37.57	-29.44
Cash Flow from Investing Activities	--	6.11	-21.58	-0.02	--	-0.02
Cash from Financing Activities	--	51.53	48.53	15.28	19.32	36.61
Net Cash Inflow / Outflow	--	--	--	--	-18.25	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.55	-1.03	-1.15	-1.41	-3.09	-3.48
Cash EPS ($)	-1.61	-1.02	-1.15	-1.40	-3.08	-3.45
Adjusted Book Value ($)	-0.14	0.40	0.61	--	0.61	2.97
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.93	-0.86	-1.16	-2.78	-3.11
Free Cash Flow per Share ($)	--	-0.93	-0.86	-1.16	-2.78	-3.11

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-162.33	-172.64	-149.88	-124.01	-81.75
ROE (%)	--	-257.67	-409.51	-869.88	-230.43	-100.73
ROA (%)	-50.06	-135.90	-137.33	-120.85	-108.08	-74.94
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-17,520.92	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-128.48	-42.98	-39.63	33.92	-23.29	-124.67
Net Profit Growth (%)	-126.19	-37.21	-33.58	28.80	-27.27	-124.42
EPS Growth (%)	-6.13	0.11	0.18	0.54	0.11	-0.46
Book Value Growth (%)	-113.06	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-4.85	-3.05	-2.92	-0.79	-2.24
Price / Book Value	64.03	12.31	5.81	-60.22	3.99	2.62
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.42	-4.54	-2.59	-3.31	-0.61	-1.39
Close Price ($)	6.53	4.97	3.52	4.12	2.45	7.78
High Price ($)	6.55	5.78	5.59	10.30	8.61	16.10
Low Price ($)	2.02	1.84	3.42	2.43	2.00	6.55
Market Cap ($ Cr)	726.49	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	-0.51	0.70	0.48	-11.55	1.95	0.53
Short term debt to equity ratio	-0.51	0.17	0.00	-11.55	1.94	0.00
Current Ratio	0.95	4.39	5.46	0.82	1.27	9.80
Quick Ratio	0.95	--	--	--	1.38	--
Interest Coverage	-113.73	-65.73	-17.27	-9.45	-22.81	-1,946.71

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	-3,993.72	-3,858.34	--
Payable days	--	2,256.38	2,047.95	1,824.65	1,935.36	856.88
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.